Cargando…
Correction: LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
Autores principales: | Shi, Xiuhui, Zhang, Hang, Wang, Min, Xu, Xiaodong, Zhao, Yan, He, Ruizhi, Zhang, Min, Zhou, Min, Li, Xu, Peng, Feng, Shi, Chengjian, Shen, Ming, Wang, Xin, Guo, Xingjun, Qin, Renyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119686/ https://www.ncbi.nlm.nih.gov/pubmed/35601605 http://dx.doi.org/10.18632/oncotarget.28216 |
Ejemplares similares
-
LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
por: Shi, Xiuhui, et al.
Publicado: (2017) -
Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018) -
Correction to: LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
por: Shi, Deyao, et al.
Publicado: (2020) -
LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma
por: Hao, Fengqin, et al.
Publicado: (2018) -
Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2019)